Who is sponsoring NCT04538209?

NCT04538209 is sponsored by Assiut University.

What drugs are being tested in NCT04538209?

Interventions in NCT04538209: Abdominal computed tomography with angiography..

What condition does NCT04538209 study?

NCT04538209 studies Portosystemic Collateral Veins.

Is NCT04538209 still recruiting?

NCT04538209 is currently status unknown. Last updated 4 September 2020.

Last reviewed 2020-09-04 · How we verify

NCT04538209

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Variceal Eradication on Portal Circulation

Status unknown Last updated 4 September 2020

What this trial tests

trial testing Abdominal computed tomography with angiography. in Portosystemic Collateral Veins in 52 participants. Status unknown.

Timeline

15 January 2021

Primary endpoint
15 April 2025

15 May 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	52
Start date	15 January 2021
Primary completion	15 April 2025
Estimated completion	15 May 2025

Drugs / interventions tested

Abdominal computed tomography with angiography.

Conditions studied

Portosystemic Collateral Veins — all drugs for Portosystemic Collateral Veins →

Sponsor

Assiut University

Who can join

Adults 18 to 70, any sex, with Portosystemic Collateral Veins. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study the effect of variceal eradication on portal circulation, liver stiffness and Child-Pugh and MELD scores in patients with liver cirrhosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04538209 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 4 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04538209.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing